These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31196492)
21. Expression of Lamininγ2 in extrahepatic cholangiocarcinoma tissues and its influence on tumor invasion and metastasis. Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG Asian Pac J Cancer Prev; 2015; 16(5):2099-102. PubMed ID: 25773857 [TBL] [Abstract][Full Text] [Related]
22. The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance. Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z Am J Med Sci; 2022 Aug; 364(2):181-191. PubMed ID: 34800429 [TBL] [Abstract][Full Text] [Related]
23. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases. Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694 [TBL] [Abstract][Full Text] [Related]
24. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma. Oshiro Y; Sasaki R; Fukunaga K; Kondo T; Oda T; Takahashi H; Ohkohchi N J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):389-95. PubMed ID: 23138964 [TBL] [Abstract][Full Text] [Related]
25. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis. Xu P; Huang Q; Xie F; Xu XL; Shao F Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827 [TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of laminin γ2 correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma. Liu W; Tian F; Jiang P; Zhao X; Guo F; Li X; Wang S J Surg Res; 2014 Jan; 186(1):150-6. PubMed ID: 24124977 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of 14-3-3 Wu Q; Fan H; Lang R; Li X; Zhang X; Lv S; He Q Biomed Res Int; 2020; 2020():8435420. PubMed ID: 32685532 [TBL] [Abstract][Full Text] [Related]
28. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma. Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403 [TBL] [Abstract][Full Text] [Related]
29. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927 [TBL] [Abstract][Full Text] [Related]
30. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance. Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944 [TBL] [Abstract][Full Text] [Related]
31. Prognostic Impact of Peritumoral IL-17-Positive Cells and IL-17 Axis in Patients with Intrahepatic Cholangiocarcinoma. Asukai K; Kawamoto K; Eguchi H; Konno M; Nishida N; Koseki J; Noguchi K; Hasegawa S; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Noda T; Wada H; Gotoh K; Marubashi S; Nagano H; Doki Y; Mori M; Ishii H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1524-31. PubMed ID: 26228109 [TBL] [Abstract][Full Text] [Related]
32. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma. Li J; Yang Z; Huang S; Li D Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031 [TBL] [Abstract][Full Text] [Related]
33. Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis. Ke Q; Wang B; Lin N; Wang L; Liu J World J Surg Oncol; 2019 Dec; 17(1):211. PubMed ID: 31818290 [TBL] [Abstract][Full Text] [Related]
34. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis. Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128 [TBL] [Abstract][Full Text] [Related]
35. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. Zhou Z; Ma J Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918 [TBL] [Abstract][Full Text] [Related]
36. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma. Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma. Sakata J; Wakai T; Matsuda Y; Ohashi T; Hirose Y; Ichikawa H; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Akazawa K; Ajioka Y Ann Surg Oncol; 2016 Jan; 23(1):225-34. PubMed ID: 25994208 [TBL] [Abstract][Full Text] [Related]
38. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection. Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811 [TBL] [Abstract][Full Text] [Related]
39. [Expressions and clinical significances of c-met, c-erbB-2, COX-2, and IL-6 in the biliary tract cancers]. Joo HH; Song EY; Jin SH; Oh SH; Choi YK Korean J Gastroenterol; 2007 Dec; 50(6):370-8. PubMed ID: 18159174 [TBL] [Abstract][Full Text] [Related]
40. The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value. Tian X; Wang Q; Li Y; Hu J; Wu L; Ding Q; Zhang C Pathol Oncol Res; 2015 Jan; 21(1):195-201. PubMed ID: 24985031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]